All Molclone commercial API packing and certificates of analysis will contain a special Hologram starting in June, 2021. Products or certificates of analysis without Holograms are not considered to be authentic. Please contact us with any verification requests: info@molclonelabs.com
Management
CEO and Managing Director
Mr. M.U.G. Thirumavalavan is a Post Graduate in Chemistry having more than three decades of experience in Research & Development of APIs and project management within the pharmaceutical and biotechnology industry. Previously, he was working at the Pharma and Biotech divisions of M/s Southern Petrochemical Corporation Limited (SPIC LTD).
Mr. Thirumavalavan has specialized in the synthesis and scale up of Active Pharmaceutical Ingredients from bench scale to production batches. As part of his role as CEO, he is leading corporate innovation and the R&D department. Mr. Thirumavalavan has developed the processes for manufacturing of Pentosan Polysulphate Sodium, Calcium L-5- Methyltetrahydrofolate and other APIs.
Director Operations
Mr.T.Vikneshkannan is a graduate with an MBA in marketing and a Bachelor of Engineering. He manages marketing and sales operations in India for FDF and globally for the complete corporate portfolio. Further, Mr.T.Vikneshkannan is leading several projects and functions in product development & manufacturing.
Head QA and Regulatory Affairs
Mr. A.R. Umare Faruk, is a Post Graduate in Chemistry having more than 2 decades experience in pharmaceutical quality assurance, quality control and regulatory affairs. He is a certified person for release of APIs and FDF. Previously, he was working at various departments of M/s Southern Petrochemical Corporation Limited (SPIC LTD).
Mr. Umare Faruk is responsible for cGMP compliance of the API manufacturing plant and the Finished Dosage Form unit. His leadership and experience in the preparation and filing of regulatory documentations. including DMFs serves Molcone and its partners located in ICH and non-ICH regulated regions.